Advertisement

Topics

Search Results for "Demodex And Psoriasis"

03:25 EDT 19th October 2017 | BioPortfolio

Matching Channels

Moderate-to-Severe Plaque Psoriasis

Psoriasis is a chronic, immune disease that affects the skin. It occurs when the immune system sends out faulty signals that speed up the growth cycle of skin cells. Psoriasis affects up to 1.8 mill...

Psoriasis and Scaling Diseases

Ixekizumab (Taltz)

Ixekizumab (Taltz) is a humanised IgG4 monoclonal antibody that selectively binds with high affinity to the interleukin 17A (IL-17A) cytokine and inhibits its interaction with the IL-17 receptor.iii...

C5a R Antagonists

The interaction of complement C5a and its receptor for the treatment of inflammatory diseases include rheumatoid arthritis, systemic lupus erythematosus, asthma, wet age-related macular degeneration...

Tumor Necrosis Factor TNF Products

Tumor Necrosis Factor (TNF) and TNF receptor antagonists and agonists used to treat TNF-mediated inflammatory diseases such as rheumatoid arthritis or to treat cancer. TNF blockers are the commerc...

Matching News

A Link Between Demodex Mites and Rosacea

The role of Demodex in rosacea appears to be well demonstrated. Since eradication of Demodex is insufficient to resolve rosacea, other pathophysiologic pathways also must be involved.

Promising new treatment option for chronic plaque psoriasis

Affecting more than 6 million Americans, chronic plaque psoriasis manifests as patches of red, scaly skin most frequently on the scalp, elbows and knees. Chronic plaque psoriasis most often appears in...

Medical News Today: Psoriasis in children: Symptoms, treatments, and causes

We look at psoriasis in children including how adult psoriasis is different, when to see a doctor, and lifestyle remedies for the condition.

Medical News Today: Why does psoriasis itch and how can I stop it?

Psoriasis is a skin condition, that may cause itchiness. Find out here about the reasons why psoriasis itches and also the most effective ways to stop it.

Medical News Today: Soap for psoriasis: All you need to know

What are the important considerations when choosing a soap for psoriasis? We look at the types of soaps available for psoriasis, and their uses.

More options for psoriasis, as Big Pharma jostles for market share

Coming soon to a screen near you: more psoriasis ads. FDA has approved J&J’s guselkumab (Tremfya) for use in moderate to se

Bioelectronic wearable shows promise in psoriasis

A non-invasive bioelectronic wearable has shown significant benefit in reducing symptoms in psoriasis patients. Affecting around 7.5 million people in the US alone, psoriasis is a chronic skin diseas...

Blockbuster Potential: How Biotech is Paving the Way to Clear Skin from Psoriasis

Though the psoriasis market is teeming with effective products, companies have developed ways to devise new, more effective modes of treatment. Psoriasis is a common autoimmune disorder that affects t...

Matching PubMed Articles

Short-Term Comfort Responses Associated With the Use of Eyelid Cleansing Products to Manage Demodex folliculorum.

To quantify the discomfort over time of various eyelid cleansers against Demodex.

Successful Secukinumab treatment of generalized pustular psoriasis and erythrodermic psoriasis.

Erythrodermic psoriasis (EP) and generalized pustular psoriasis (GPP) are the most severe forms of psoriasis, resulting in significant morbidity and even mortality (1) . There are few evidence-based d...

Patch testing in psoriasis patients: results of a 30-year retrospective study.

Psoriasis and allergic contact dermatitis (ACD) are common, chronic T-lymphocyte mediated conditions. Although psoriasis patients are commonly referred for patch testing, there are conflicting views o...

Psoriasis and Obesity.

Psoriasis is a common chronic inflammatory skin disease with a complex pathogenesis consisting of a genetic component, immune dysfunction, and environmental factors. It is associated with numerous com...

Measurement Properties of the Psoriasis Symptom Inventory Electronic Daily Diary in Patients with Moderate to Severe Plaque Psoriasis.

The Psoriasis Symptom Inventory (PSI) is a patient-reported outcome instrument that measures the severity of psoriasis signs and symptoms. This study evaluated measurement properties of the PSI in pat...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement